pocketful logo
Shukra Pharmaceuticals Ltd logo

Shukra Pharmaceuticals Ltd

NSE: BSE: 524632

42.09

(-1.20%)

Thu, 12 Mar 2026, 01:39 pm

Shukra Pharmaceuticals Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    1837.34

  • Net Profit

    9.58

  • P/B

    15.17

  • Sector P/E

    32.85

  • P/E

    99.32

  • EV/EBITDA

    56.04

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.89

  • ROCE (Industry)

    16.43

  • RONW (Industry)

    14.36

  • ROE

    15.90

  • ROCE

    21.76

  • Debt/Equity

    0.06

  • EPS (TTM)

    0.67

  • Dividend Yield

    0.02

  • Book Value

    0.25

  • Interest Cover

    23.61

Analysis

all

thumbs up icon

Pros

  • Dividends paid are thoroughly covered by earnings (10.9x coverage).
  • Shukra Pharmaceuticals's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Shukra Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Shukra Pharmaceuticals is profitable, therefore cash runway is not a concern.
  • Shukra Pharmaceuticals is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Shukra Pharmaceuticals has only been paying a dividend for 3 years, and since then there has been no growth.
  • Whilst dividend payments have been stable, Shukra Pharmaceuticals has been paying a dividend for less than 10 years.
  • Shukra Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Debt is not well covered by operating cash flow (4%, less than 20% of total debt).
  • The level of debt compared to net worth has increased over the past 5 years (1.9% vs 41.1% today).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters50.9650.9650.9650.9650.96
FII00000
DII0.110.110.110.110.11
Public48.9348.9348.9348.9348.93
Government00000

Read More

Technical Analysis

RSI

46.51

MACD

-0.53

50 DMA

44.16

200 DMA

33.42

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic66.0153.3747.3040.7334.6628.0915.45
Fibonacci53.3748.5445.5640.7335.9032.9228.09
Camarilla44.7243.5642.4040.7340.0838.9237.76

Pivots Level: Classic

R3

+25.28

66.01

R2

+12.64

53.37

R1

+6.58

47.30

40.73
40.73
Pivot Point
LTP: 40.09

S1

-6.06

34.66

S2

-12.64

28.09

S3

-25.28

15.45

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    41.00

  • 20-EMA

    41.13

  • 30-EMA

    41.76

  • 50-EMA

    42.67

  • 100-EMA

    41.44

  • 200-EMA

    35.72

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
04 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results
04 Oct 2025egm
30 Aug 2025agm
18 Aug 2025dividendFinal Dividend - Rs. - 0.0118 Sept 2025
04 Jun 2025dividend₹0.01 Dividend /Share18 Sept 2025
21 Feb 2025splitStock Split From Rs.10 to Rs.121 Mar 2025
29 Jan 2025split1:10 Splits of Equity Shares21 Mar 2025
15 Sept 2024agm
30 Jul 2024egm

Read More

Peer Comparison

Shukra Pharmaceuticals Ltd logo

Shukra Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Shukra Pharmaceuticals Ltd About

Shukra Pharmaceuticals is engaged primarily in the business of manufacture and marketing of pharmaceutical products.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1993

Headquarters

CEO

Dakshesh Shah

Employees

Contact

Website icon

Website

http://www.shukrapharmaceuticals.com

Email icon

Email

info@shukrapharmaceuticals.com

Phone icon

Phone

91-079-66522247/27498515

Location icon

Location

3 rd Floor Dev House, Opp WIAA Office Judges Bungalo, Ahmedabad, Gujarat, 380054

Read More

Shukra Pharmaceuticals Ltd Company History

YearHistory
No Result Found

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
No Result Found

Read More

Shukra Pharmaceuticals Ltd News

Shukra Pharma Q3FY26 Net Profit Surges 543% YoY

Shukra Pharmaceuticals reports exceptional Q3FY26 performance with net profit jumping 543% to ₹2,036.46 lakhs and revenue growing 270% YoY. Nine-month profits soar 467% to ₹2,377.46 lakhs.

04 Feb 2026

co actions results

Shukra Pharma Allots 46.43L Convertible Warrants

Shukra Pharmaceuticals allots 46,43,000 convertible equity warrants to promoters at ₹34 per warrant, raising ₹3.95 crore upfront with potential total of ₹15.79 crore.

28 Jan 2026

co actions results

Shukra Pharma postal ballot passes with 99.99% votes

Shukra Pharmaceuticals' postal ballot for continuing independent director Jitendra Shah beyond 75 years approved with overwhelming 99.99% support through remote e-voting process.

05 Jan 2026

stocks

Shukra Pharma Partners with US Robotics Firm

Shukra Pharmaceuticals signs MOU with Borns Medical Robotics Inc. to commercialize AI-enabled surgical robotic systems across India and South Asian markets through subsidiary.

05 Jan 2026

co actions results

Shukra Pharmaceuticals Board Changes on Dec 30

Shukra Pharmaceuticals appointed Dinesh Chauhan as Additional Independent Director while Bhoomi Patel resigned from the board, leading to committee reconstitution.

30 Dec 2025

stocks

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800